REQUEST A DEMO
Total
USD $0.00
Search more companies

Patar Lab (2517) Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Patar Lab (2517) Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Patar Lab (2517) Company Limited is based in Thailand. The head office is in Pathum Thani. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on May 22, 2026. It currently has a total number of 150 (estimated) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 3.36% in 2024. During that time, Patar Lab (2517) Company Limited’s total assets grew by 13.57%. The net profit margin of Patar Lab (2517) Company Limited increased by 0.48% in 2024.

Headquarters
51 Moo 3 Liap Khlong 7( Thanyaburi-Lamlukka) Road
Pathum Thani; Central Thailand; Postal Code: 12150

Contact Details: Purchase the Patar Lab (2517) Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Patar Lab (2517) Company Limited report to view the information.
Financial Auditors:
Purchase the Patar Lab (2517) Company Limited report to view the information.
Incorporation Date:
May 22, 2026
Key Executives
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Patar Lab (2517) Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
3.36%
Total Operating Revenue
3.89%
Operating Profit
12.08%
EBITDA
12.08%
Net Profit/Loss for the Period
7.68%
Total Assets
13.57%
Total Equity
13.72%
Operating Profit Margin
1.29%
Net Profit Margin
0.48%
Return on Equity (ROE)
-0.68%
Debt / Equity
-3.01%
Quick Ratio
1.79%
Cash Ratio
-3.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?